ExplORer Surgical
Cloud-based platform for operating rooms that improves communication and coordination among surgical teams.
Website: www.explorersurgical.com
Cover Block
Public sources
| Field | Value |
|---|---|
| Name | ExplORer Surgical [Bloomberg Markets, retrieved 2026] |
| Tagline | Cloud-based platform for operating rooms that improves communication and coordination among surgical teams [MedCity News, April 2019] |
| Headquarters | Chicago, United States [Crunchbase, retrieved 2026] |
| Founded | 2015 [Medill Reports Chicago, retrieved 2026] |
| Stage | Series A [Crunchbase, retrieved 2026] |
| Business model | SaaS [Crunchbase, retrieved 2026] |
| Industry | Healthtech [Crunchbase, retrieved 2026] |
| Technology type | Software (Non-AI) [Bloomberg Markets, retrieved 2026] |
| Geography | North America [Crunchbase, retrieved 2026] |
| Growth profile | Venture Scale [Crunchbase, retrieved 2026] |
| Founding team | Academic Spinout [MedCity News, April 2019] |
| Funding label | Series A |
| Total disclosed | ~$10,600,000 [MedCity News, April 2019] [MedTech Innovator, April 2021] [Startup Intros, retrieved 2026] |
Links
Public sources
- Website: https://explorersurgical.com
Executive Summary
PUBLIC ExplORer Surgical builds cloud software for the operating room, and it merits investor attention because public reporting shows a clear wedge into both hospital workflows and medical device company case support, with disclosed financing extending through 2021 before a later acquisition by GHX [MedCity News, April 2019] [MedTech Innovator, April 2021] [GHX, 2021]. The company was founded in 2015 in Chicago by Jennifer Fried and Alex Langerman, and its origin story is unusually grounded in a hospital research setting rather than a generic workflow thesis, with the underlying technology initially developed at The University of Chicago Medical Center [Medill Reports Chicago, retrieved 2026] [GHX, 2021].
The product has been described across public sources as a cloud-based operating room platform or digital playbook that improves intraoperative communication, coordination, and workflow standardization, and by 2019 the company had expanded from an initial hospital workflow tool into a platform that also let medical device companies observe and analyze operating room activity [MedCity News, April 2019] [Chicago Innovation, retrieved 2026] [Bloomberg Markets, retrieved 2026]. That buyer expansion looks like the key differentiator in the record: instead of selling only into provider IT budgets, ExplORer Surgical appears to have built relevance for device makers supporting procedures in the field, including remote case support features launched in 2020 [MedCity News, April 2019] [OrthoFeed, September 2020].
The founding team’s fit is credible on paper, if still mostly documented through company-adjacent and profile sources: Fried is publicly identified as co-founder and CEO, with ties to Chicago Booth, while Langerman is described as a surgeon and operating room efficiency researcher who helped develop the technology in its early form [MedCity News, April 2019] [Polsky Center for Entrepreneurship and Innovation, April 2021] [MedtechMVP, retrieved 2026]. That combination, operator plus clinical domain expert, is consistent with the product’s workflow orientation, though the public record is thinner on later go-to-market leadership depth than on the original founding story [Medill Reports Chicago, retrieved 2026] [BackTable, retrieved 2026].
On capital, the company’s disclosed rounds total about $10.6 million across a 2016 seed, a 2017 Series A, a $5 million 2019 financing led by Aphelion Capital, and a roughly $2.6 million 2021 raise; the business model is software sold on a SaaS basis, with both hospitals and device companies cited as customers [Startup Intros, retrieved 2026] [MedCity News, April 2019] [MedTech Innovator, April 2021]. Over the next 12 to 18 months, the central question for investors is less about product concept than about commercial durability: the public evidence points to customer additions and feature expansion, but it does not yet establish revenue scale, renewal behavior, or the relative weight of hospital versus device-company demand [MedTech Innovator, April 2021] [Craft.co, March 2021].
Company-stated, unverified -- Core company history is supported by multiple public sources, but most product, customer, and team-detail claims rely on company-adjacent coverage and profiles rather than independently corroborated operating data.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Series A |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding | ~$10.6M disclosed |
How the Company Got Here
PUBLIC
ExplORer Surgical traces back to a clinical workflow problem rather than a consumer software idea. Public company-profile sources place the business in Chicago, list 2015 as the founding year, and identify Jennifer Fried and Alex Langerman as founders, which is consistent with the company’s positioning as an operating-room workflow software provider [Crunchbase].
The public record is thin on formal corporate detail, but the chronology is serviceable. Crunchbase shows an early $1 million seed round in 2016, followed by a $3 million Series A in 2017, a $5 million financing in April 2019, and roughly $2.6 million more reported in April 2021, for total disclosed funding of about $10.6 million [Crunchbase]. That funding path suggests a company that continued to finance product expansion after its initial hospital use case, without any public evidence here of a later priced growth round or a separate change in headquarters [Crunchbase].
A material endpoint in the public timeline is the 2021 acquisition by Global Healthcare Exchange. GHX said in 2021 that ExplORer Surgical’s technology had initially been developed at the University of Chicago Medical Center by Jennifer Fried and Dr. Alex Langerman, which aligns with the academic-spinout framing and helps explain the company’s early credibility inside perioperative workflows [GHX, 2021].
Lightly corroborated -- Relies primarily on Crunchbase for founding, headquarters, and financing chronology, with GHX providing partial corroboration on origin and founders.
Product and Technology
MIXED Product surface and workflow
ExplORer Surgical’s product story is easiest to understand as workflow software for the operating room, not as a novel device or an AI layer. Public sources consistently describe a cloud-based platform built to improve communication and coordination among surgical team members, first in hospital settings and later in interactions involving medical-device companies observing or supporting procedures [MedCity News, April 2019] [Bloomberg Markets] [Built In Chicago].
The core product appears to center on a digital or interactive surgical playbook used during procedures. Across company-adjacent profiles and event materials, that playbook is described as helping standardize intraoperative communication, reduce disruptions or wasted disposables, and embed surgeon-customized best practices into workflow, with analytics available after the case [DeviceTalks Minnesota] [Chicago Innovation] [Built In Chicago]. MedCity News also reported that the company expanded beyond its original hospital workflow tool into a platform for medical-device companies to observe and analyze operating-room activity, which suggests a dual-sided workflow product rather than a single-purpose hospital application [MedCity News, April 2019].
MIXED Remote support and data layer
By late 2020, the company had publicly tied the platform to remote case support. OrthoFeed reported in September 2020 that ExplORer Surgical launched updated real-time audio, video, and data-collection features, framing the software as a way for device companies and surgical teams to reduce procedural variability and execute a customized digital playbook during cases [OrthoFeed, September 2020]. Chicago Innovation separately described the platform as providing real-time performance and scheduling data to administrators, which points to an operational analytics layer in addition to the in-room workflow interface [Chicago Innovation].
What is less clear from the public record is the underlying technical architecture beyond the company’s repeated use of the term cloud-based. There is no verified public evidence here for a specific stack, model layer, interoperability standard, or deployment architecture, and the available materials do not establish predictive capabilities. The conservative read is that differentiation rests on procedure-specific workflow design, case collaboration, and data capture inside the operating room rather than on a disclosed proprietary infrastructure claim [MedCity News, April 2019] [OrthoFeed, September 2020] [Chicago Innovation].
Company-stated, unverified -- This section relies primarily on company-adjacent descriptions and press coverage, with partial corroboration across MedCity News, OrthoFeed, Bloomberg Markets, and organization profiles.
Where the Demand Sits
PUBLIC
The market matters because ExplORer Surgical sits at the intersection of hospital workflow software and medtech field support, two budgets that have been pressured to show clearer productivity gains since the pandemic reshaped how procedures are staffed and observed [MedCity News, April 2019] [OrthoFeed, September 2020].
The public record here is thinner than an institutional reader would want for a clean TAM build. No named third-party market sizing report is provided in the source set for surgical workflow software, intraoperative collaboration, or remote case support, so any market framing has to stay qualitative rather than pretend to precision. What is verifiable is the buyer pattern: the company started with a hospital workflow product and later expanded into a device-company-facing platform for observing and analyzing operating-room activity after medtech companies began approaching it in 2017 [MedCity News, April 2019]. That matters because it places the business in an adjacent market structure, part clinical operations software, part commercial enablement software for device manufacturers, rather than in a single narrow hospital IT bucket [MedCity News, April 2019] [Bloomberg Markets].
Demand drivers in the cited material are operational rather than discretionary. The product is described across sources as a digital or interactive surgical playbook intended to improve intraoperative communication, reduce disruptions, limit wasted disposables, and generate analytics for administrators or device-company users [DeviceTalks Minnesota] [Chicago Innovation] [Built In Chicago] [OrthoFeed, September 2020]. Those claims line up with a period when remote support tools became more relevant: in September 2020, the company announced remote case support features spanning real-time audio, video, and data collection, which suggests demand was being pulled not only by core OR workflow needs but also by restrictions on in-person presence and a broader push to digitize procedural observation [OrthoFeed, September 2020].
The clearest adjacent markets are perioperative operations software, telepresence-enabled procedural support, and medtech commercial software used around case coverage and product utilization. ExplORer Surgical does not appear, from the supplied evidence, to compete as an electronic health record vendor or as a surgical robotics company. Instead, its positioning looks closer to workflow infrastructure layered around procedures, with relevance to hospitals that want better coordination and to device manufacturers that want visibility into what happens in the room during product use [MedCity News, April 2019] [GHX, 2021]. The 2021 acquisition by GHX is also a useful market signal, not as a valuation proxy, but as evidence that supply-chain and healthcare network platforms saw strategic value in workflow data generated inside the operating room [GHX, 2021].
Regulatory and macro forces are present mostly by implication in the cited record. Hospital systems have faced persistent pressure to improve throughput, standardization, and resource use, while medtech companies have had to support cases with more distributed field teams and tighter compliance around who can be present and what data is captured. The source set does not provide a named regulatory change that directly expands this market, so the safer reading is that adoption is tied to operational efficiency and documentation needs rather than a single policy catalyst. On the demand side, the company-reported addition of more than 10 medical-device customers by March 2021, including Prytime, indicates that the medtech segment may have been the faster-moving buyer cohort, even if that traction point remains company-sourced rather than independently verified [MedTech Innovator, April 2021] [Craft.co, March 2021].
| Market lens | What the sources support | Evidence |
|---|---|---|
| Core market | Operating-room workflow and intraoperative coordination software | ExplORer Surgical is described as a cloud-based OR platform and intraoperative workflow management tool [MedCity News, April 2019] [Bloomberg Markets] |
| Adjacent market | Medtech-facing case observation and analysis software | The company expanded into a platform for device companies to observe and analyze OR activity [MedCity News, April 2019] |
| Pandemic-era tailwind | Remote case support and real-time audio, video, and data collection | New remote case support features were launched in September 2020 [OrthoFeed, September 2020] |
| Strategic buyer signal | Healthcare network or supply-chain platforms valuing OR workflow data | GHX acquired the company in 2021 [GHX, 2021] |
The market picture is credible but narrow. Public evidence supports a real wedge around surgical workflow and device-company case support, but it does not support a quantified market size claim without reaching beyond the sourced record.
Company-stated, unverified -- This section relies primarily on company-descriptive coverage and acquisition communications, with no independent third-party market sizing report in the provided sources.
Competitive Landscape
MIXED ExplORer Surgical appears to sit between hospital workflow software and medtech field-support tools, with its clearest positioning in procedure-level coordination inside the operating room rather than in the full-stack clinical record or surgical robotics layers [MedCity News, April 2019] [Bloomberg Markets] [OrthoFeed, September 2020].
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| ExplORer Surgical | Operating-room workflow and communication software used by surgical teams and medtech companies | Series A, about $10.6M disclosed | Started with hospital workflow, then expanded into device-company observation and analysis of OR activity | [MedCity News, April 2019] [MedTech Innovator, April 2021] [Startup Intros] |
| SeamlessMD | Digital care journey software for patients and providers around surgical episodes | Not established from provided sources | Competes more upstream and downstream of the procedure itself, rather than primarily inside the intraoperative moment | [Structured Facts] |
| Epic | Core hospital software and clinical systems | Not established from provided sources | Owns the incumbent health-system relationship and the broader system of record | [Structured Facts] |
| Digital Surgery | Surgical technology competitor named in structured research | Not established from provided sources | Named competitor with overlap in digital surgical workflow and analytics themes | [Structured Facts] |
| Avail | Remote presence and support competitor named in structured research | Not established from provided sources | Overlaps most directly with remote case support after ExplORer added audio, video, and data features in 2020 | [Structured Facts] [OrthoFeed, September 2020] |
The competitive map breaks into three lanes.
ExplORer Surgical's edge, on the public record, is less about owning the full care continuum and more about solving a narrow, operational problem at procedure time. MedCity News reported that the company began in a hospital research lab and then found a second buyer segment when medical-device companies approached it, leading the product to expand from hospital workflow into a platform for observing and analyzing OR activity [MedCity News, April 2019]. That cross-sided relevance matters because it can create two distribution paths, hospitals and device makers, but the durability of the edge is less certain because the available sources do not establish proprietary integrations, regulatory barriers, or a scale data moat that would be difficult for a larger platform to replicate.
The exposure is clearer. Avail also appears relevant because ExplORer publicly launched remote case support features with real-time audio, video, and data collection in 2020, which suggests overlap with vendors that make remote intraoperative support a primary product rather than an added module [OrthoFeed, September 2020].
The most plausible 18-month scenario, based only on the public record here, is continued consolidation around vendors that can show they serve both procedural coordination and commercial field support. Winner if cross-functional medtech demand remains the main buying driver: Avail, because remote support can become the anchor use case if hospitals and device reps keep normalizing virtual case participation [OrthoFeed, September 2020]. Loser if enterprise hospital IT standardization tightens: ExplORer Surgical, because its reported differentiation rests on workflow specificity and medtech-facing observation rather than on control of the core clinical system or a disclosed installed-base advantage [MedCity News, April 2019] [Bloomberg Markets].
Opportunity
PUBLIC
The prize here is not a better surgical checklist, it is a software layer that becomes routine inside operating rooms and medtech field workflows, two budgets that touch high-value procedures and tend to persist once embedded [MedCity News, April 2019] [GHX, 2021].
The headline opportunity is straightforward: ExplORer Surgical could plausibly become the workflow system of record for intraoperative coordination and case support across hospitals and medical-device companies. That outcome is still conditional, but it is not abstract. Public reporting shows the company started with hospital workflow, then found stronger pull from device manufacturers that wanted to observe and analyze operating-room activity, effectively broadening its buyer set rather than replacing it [MedCity News, April 2019]. By September 2020, it had also added remote case support features spanning audio, video, and data capture, which suggests a product surface that can support both in-room execution and distributed clinical support workflows [OrthoFeed, September 2020].
The reason this matters economically is that procedural workflow software sits close to recurring behavior rather than one-off purchasing. ExplORer Surgical's own public positioning across multiple outlets is consistent on that point: a digital playbook used during procedures, aimed at reducing disruptions, standardizing best practices, and producing analytics for administrators or device-company users [Chicago Innovation] [DeviceTalks Minnesota] [Bloomberg Markets]. If software becomes part of how cases are prepared, observed, and reviewed, replacement gets harder over time, particularly when both providers and industry teams are using the same system in adjacent workflows [MedCity News, April 2019].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Medtech control point | The company becomes the default workflow and remote support layer for device representatives and clinical teams during complex procedures. | The September 2020 launch of remote case support features expands the product from in-room coordination to distributed observation and support [OrthoFeed, September 2020]. | Public reporting already shows medical-device companies became a larger customer base, and the company said it added more than 10 new device customers by March 2021 [MedCity News, April 2019] [MedTech Innovator, April 2021]. |
| Cross-side workflow network | The platform wins on both sides of the procedure, hospitals for workflow standardization and device companies for visibility and analytics, creating a shared operating layer. | The shift from an initial hospital workflow product into a device-company-facing platform broadened the addressable workflow without changing the clinical setting [MedCity News, April 2019]. | The company originated in a hospital research environment but found commercial demand from industry users, a pattern that can support two-sided distribution if adoption persists [MedCity News, April 2019] [GHX, 2021]. |
| Strategic infrastructure inside a larger healthcare network | The product becomes a specialized procedural workflow asset inside a broader supply-chain or hospital operations platform. | GHX acquired ExplORer Surgical in 2021, giving the product a route into an established healthcare commerce and operations network [GHX, 2021]. | A strategic buyer has already signaled that intraoperative workflow data and coordination matter enough to buy, not just partner for, which supports the idea that this category can accrue strategic value beyond standalone software revenue [GHX, 2021]. |
These scenarios point to the same compounding mechanism. Each procedure run through a digital playbook can make the software more useful to the next user, because the workflow logic, observed disruptions, disposable usage patterns, and support requirements become easier to standardize and reuse if the product is already present in the room [DeviceTalks Minnesota] [Chicago Innovation]. The available evidence is still company-leaning, so caution is warranted, but there are early signs of a flywheel: expansion from hospitals into medtech, feature growth into remote support, and reported customer adds in the device segment over a short period [MedCity News, April 2019] [OrthoFeed, September 2020] [MedTech Innovator, April 2021].
The distribution side may matter as much as the product side. Once a platform is adopted by device companies that need repeatable support across many sites, each new account can create pressure for broader procedural coverage, more configured playbooks, and deeper administrative reporting. If that then feeds back into hospital adoption, the company moves from point solution toward workflow infrastructure. GHX's acquisition is relevant here because it suggests a larger incumbent saw enough adjacency between procedural coordination and its existing healthcare network to make the asset strategic [GHX, 2021].
The size of the win is best framed through strategic value rather than a precise public-market comparable, because the source set here does not establish revenue or valuation. A reasonable upside case is that software connecting intraoperative workflow, remote case support, and procedural analytics becomes important enough to command premium strategic interest from healthcare IT, supply-chain, or medtech platforms, as GHX's 2021 acquisition already indicates at a smaller scale [GHX, 2021]. If the "Cross-side workflow network" scenario plays out, the business could support enterprise-software style value creation as a category asset embedded in recurring procedural operations, potentially reaching a high nine-figure outcome or better (scenario, not a forecast). That range is an analytical scenario, not an observed valuation, and it depends on repeatable adoption well beyond what public disclosures currently prove.
Company-stated, unverified -- This section relies on company-adjacent and acquisition-source reporting, with limited independent corroboration beyond MedCity News, MedTech Innovator, and GHX.
Sources
Public sources
[Bloomberg Markets, retrieved 2026] ExplORer Surgical Corp - Company Profile and News - Bloomberg Markets | https://www.bloomberg.com/profile/company/1438634D:US
[MedCity News, April 2019] ExplORer Surgical raises $5M for its cloud-based platform for the operating room | https://medcitynews.com/2019/04/explorer-surgical-raises-5m/
[Crunchbase, retrieved 2026] ExplORer Surgical - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/explorer-surgical
[MedTech Innovator, April 2021] Explorer Surgical raises nearly $2.6M | https://medtechinnovator.org/cohortnews/explorer-surgical-raises-nearly-2-6m
[Startup Intros, retrieved 2026] ExplORer Surgical: Funding, Team & Investors | Startup Intros | https://startupintros.com/orgs/explorer-surgical
[GHX, 2021] Global Healthcare Exchange Announces Acquisition of Explorer Surgical | GHX | https://www.ghx.com/news-releases/2021/global-healthcare-exchange-announces-acquisition-of-explorer-surgical/
[Medill Reports Chicago, retrieved 2026] ExplORer Surgical programs surgical guides to optimize OR safety and procedures - Medill Reports Chicago | https://news.medill.northwestern.edu/chicago/explorer-surgical-programs-surgical-guides-to-optimize-or-safety-and-procedures/
[Chicago Innovation, retrieved 2026] ExplORer Surgical - Chicago Innovation | https://chicagoinnovation.com/winners/explorer-surgical/
[OrthoFeed, September 2020] ExplORer Surgical Launches New Remote Case Support Features, Updating Real-Time Audio, Video and Data Collection Capabilities - OrthoFeed | https://orthofeed.com/2020/09/19/explorer-surgical-launches-new-remote-case-support-features-updating-real-time-audio-video-and-data-collection-capabilities/
[Polsky Center for Entrepreneurship and Innovation, April 2021] Where Are They Now? Episode 2 - Polsky Center for Entrepreneurship and Innovation | https://polsky.uchicago.edu/where-are-they-now-episode-2/
[DeviceTalks Minnesota, retrieved 2026] Jennifer Fried | DeviceTalks Minnesota | https://minnesota.devicetalks.com/speaker/jennifer-fried/
[Craft.co, March 2021] Onboarded more than 10 new medical device customers, including some of the largest global MedTech companies and startup companies like Prytime | https://craft.co/explorer-surgical
Articles about ExplORer Surgical
- ExplORer Surgical Convinced Device Giants to Watch the Operating Room — The Chicago startup, born in an OR research lab, pivoted to serve the medical device industry, raising funds from Aphelion Capital and the University of Chicago.